Moderna’s anti-corona vaccine made $7 billion in profits in the fourth quarter of 2021, and the company signed purchase deals with another $19 billion in sales.
For the whole of 2021, the profits of Moderna exceeded twelve billion dollars, while the company expects its profits in 2022 to range between 17 billion and 22 billion dollars.